Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1203112 | 1.00 | CHRM2 (0.35) | CHRM2CHRM4CHRM1CHRM3GAA | |
| SCHEMBL17627722 | 0.89 | SLC18A3 (0.32) | — | |
| SCHEMBL1427774 | 0.88 | POLB (0.41) | CHRM2CHRM4CHRM1CHRM3GAA | |
| SCHEMBL17836876 | 0.83 | CHRM2 (0.33) | CHRM2CHRM4CHRM1CHRM3GAA | |
| SCHEMBL114981 | 0.83 | CHRM2 (0.33) | CHRM2CHRM4CHRM1CHRM3GAA | |
| SCHEMBL18604001 | 0.83 | CHRM2 (0.33) | CHRM2CHRM4CHRM1CHRM3GAA | |
| SCHEMBL12919752 | 0.81 | HMGCR (0.33) | — | |
| SCHEMBL18397998 | 0.79 | GAA (0.30) | GAAPOLB | |
| SCHEMBL2970207 | 0.79 | GAA (0.30) | GAAPOLB | |
| SCHEMBL29564962 | 0.79 | GAA (0.30) | GAAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| EP-3325588-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-16 | — | — | EP | claimed |
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| EP-3429641-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-07-03 | — | — | EP | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | claimed |
| US-20210040415-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2021-02-11 | — | — | US | claimed |
| US-10899995-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2021-01-26 | — | — | US | claimed |
| US-20190345411-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2019-11-14 | — | — | US | claimed |
| WO-2019193024-A1 | IMPROVEMENTS IN OR RELATING TO A PERFUME COMPOSITION FOR USE IN AN AIR FRESHENER DEVICE | GIVAUDAN SA (CH) | 2019-10-10 | — | — | WO | claimed |
| US-10407644-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2019-09-10 | — | — | US | claimed |
| EP-3429641-A1 | PERFUME COMPOSITIONS | Givaudan S.A. (CH) | 2019-01-23 | — | — | EP | claimed |
| US-20180100121-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-04-12 | — | — | US | claimed |
| US-9868923-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2018-01-16 | — | — | US | claimed |
| WO-2017157824-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-21 | — | — | WO | claimed |
| US-20170260476-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | CHRM2 3153/4885CHRM4 3868/4885CHRM1 2378/4885 |
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | CHRM2 976/4885CHRM4 655/4885CHRM1 421/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | CHRM2 3453/4885CHRM4 2576/4885CHRM1 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.